Pharmacological Treatment of Acute Coronary Syndromes
Secondary prevention in ACS: The role of novel oral anticoagulants
Publication
, Chapter
Kang, HJ; Roe, MT
January 1, 2014
Duke Scholars
Citation
APA
Chicago
ICMJE
MLA
NLM
Kang, H. J., & Roe, M. T. (2014). Secondary prevention in ACS: The role of novel oral anticoagulants. In Pharmacological Treatment of Acute Coronary Syndromes (pp. 123–138). https://doi.org/10.1007/978-1-4471-5424-2_4
Kang, H. J., and M. T. Roe. “Secondary prevention in ACS: The role of novel oral anticoagulants.” In Pharmacological Treatment of Acute Coronary Syndromes, 123–38, 2014. https://doi.org/10.1007/978-1-4471-5424-2_4.
Kang HJ, Roe MT. Secondary prevention in ACS: The role of novel oral anticoagulants. In: Pharmacological Treatment of Acute Coronary Syndromes. 2014. p. 123–38.
Kang, H. J., and M. T. Roe. “Secondary prevention in ACS: The role of novel oral anticoagulants.” Pharmacological Treatment of Acute Coronary Syndromes, 2014, pp. 123–38. Scopus, doi:10.1007/978-1-4471-5424-2_4.
Kang HJ, Roe MT. Secondary prevention in ACS: The role of novel oral anticoagulants. Pharmacological Treatment of Acute Coronary Syndromes. 2014. p. 123–138.